SAN DIEGO, Feb. 25, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, both dates inclusive (the “Class Period”), have until Monday, March…

Super Insoles Engineered for Everyday Use, Inspired by Super Shoes, Feature High-Energy Return PEBAX® Polymer Foam & Cutting-Edge Propulsive ARRIS® Carbon Fiber Plates BERKELEY, Calif., Feb. 25, 2025 /PRNewswire/ — ARRIS® Composites, an advanced manufacturer with breakthrough carbon…

NEW YORK, Feb. 25, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Monolithic Power Systems, Inc. (“Monolithic” or the “Company”) (NASDAQ: MPWR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980,…

NEW YORK, Feb. 25, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NASDAQ: HII). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980,…

NEW YORK, Feb. 25, 2025 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext….

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.